Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in AYTU — Aytu Biopharma, Inc

CIK 916542 Boston, MA
Back to AYTU Full portfolio

Position in AYTU

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$22,009
-$5,938 QoQ
Shares Held
10,237
0.0% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 38 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AYTU Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $533,943,071 across 32 Drug Manufacturers - Specialty & Generic names. AYTU ranks #31 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 318,320 $172,475,325
2 NBIX
Neurocrine Biosciences Inc
 441,371 $74,388,668
3 KNSA
Kiniksa Pharmaceuticals International, plc
 679,083 $43,427,357
4 RDY
Dr Reddys Laboratories Ltd
 2,260,243 $32,750,921
5 INDV
Indivior Pharmaceuticals, Inc.
 733,974 $30,114,953
6 AMRX
Amneal Pharmaceuticals, Inc.
 1,650,255 $28,565,914
7 BHC
Bausch Health Companies Inc.
 5,482,986 $27,031,120
8 ZTS
Zoetis Inc.
 364,442 $26,188,802

All Filings in AYTU

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,009 10,237
2026-03-31 $27,947 10,237
2025-12-31 $26,616 10,237
2025-09-30 $19,245 10,237
2025-06-30 $22,316 10,237
2025-03-31 $17,546 14,622
2024-12-31 $24,857 14,622
2024-09-30 $34,361 14,622
2024-06-30 $42,696 14,622
2024-03-31 $44,450 14,622
2023-12-31 $41,526 14,622
2023-09-30 $60,849 22,537
2023-06-30 $36,059 22,537
2023-03-31 $50,482 22,537
2022-12-31 $75,607 397,936